Vaginal Mesh

Vaginal mesh is touted as a “minimally invasive” method to treat pelvic organ prolapse and stress urinary incontinence. It can also come with life-altering complications. Thousands of adverse reactions, including three deaths, have now been linked to failed mesh.

Read more about Vaginal Mesh

Photo of a Canadian flag after Canada removes transvaginal mesh from the market following a safety review.

Canada Removes Transvaginal Mesh From Market, Still Available for Some

Nicole Knight · August 9, 2019

Health Canada announced the removal of transvaginal mesh from the market following a safety review. However, transvaginal mesh will still be available for women with pelvic organ prolapse (POP) in some cases.

News
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of Billie Copley next to a photo of Jennifer Snowden, two women injured by transvaginal mesh.

Stories Not Statistics: Faces of Transvaginal Mesh

Carah Wertheimer · May 31, 2019

For Pelvic Pain Awareness Month, MedTruth is sharing patient stories. We're recognizing two transvaginal mesh survivors living with chronic pain. For Billie Copley, 44, and Jennifer Snowden, 34, transvaginal mesh implants have changed their lives forever.

Patient Stories
A photo of a woman with transvaginal mesh after news of Transvaginal Mesh Sales Halted by FDA.

FDA Stops Sales of Transvaginal Mesh

Carah Wertheimer · April 19, 2019

The FDA gave transvaginal mesh companies Boston Scientific and Coloplast 10 days to submit plans to withdraw their products from the market - officially ending transvaginal mesh sales. Unfortunately for many, the damage has been done.

FDA Regulation
An illustration of vaginal mesh, representing a vaginal mesh trial showing risk and ineffectiveness.

Largest Trial Shows Vaginal Mesh Isn’t More Effective Than Standard Repair

Ashley Lombardo · January 30, 2017

In a vaginal mesh trial, researchers found the devices pose unnecessary risks and are no more effective than standard repair.

Research + Findings
An illustration of a gavel, related to the New Jersey mesh settlement for Linda Gross, a South Dakota nurse, who survived transvaginal device complications.

New Jersey Court Awards $11 Million Mesh Settlement to Survivor

Ashley Lombardo · January 16, 2017

A New Jersey court awarded a mesh settlement more than $11 million to a South Dakota nurse surviving transvaginal mesh complications.

Legal Developments
An illustration of the Food and Drug Administration's safety communication on vaginal mesh warnings.

FDA Updates Vaginal Mesh Warning and Risk Classification

Ashley Lombardo · October 7, 2016

The Food and Drug Administration released a vaginal mesh warning, updating the public on mesh side effects.

FDA Regulation
An illustration of questions to ask before mesh surgery checklist on a clipboard.

FDA Recommends Questions to Ask Before Mesh Surgery

Ashley Lombardo · September 28, 2016

The Food and Drug Administration released a set of questions to ask before mesh surgery to reduce the number of vaginal mesh side effects, the

FDA Regulation